Connect & Inspire

Share Your Story

Explore & Discover

Treatment & Care

Press Room

Subscribe

A Life With Osteosarcoma but Without Limits

Osteosarcoma survivor and five-time Paralympian carries the torch for disabled athletes and cancer survivors alike.

LATEST POSTS

Connect & Inspire

Stories of inspiration, community, and survival 

A Second Mission to Overcome Osteosarcoma

A Second Mission to Overcome Osteosarcoma

Armond says family, students and connecting with others give him the courage and strength to fight osteosarcoma once again.
Two-time Osteosarcoma Survivor Never Let Cancer Define His Life

Two-time Osteosarcoma Survivor Never Let Cancer Define His Life

Carlos was diagnosed with osteosarcoma when he was 17 and again when he was 20. But, through it all, he never lost his passion for life.
After Rotationplasty Surgery, Jani Learns to Accept and Embrace Her Body

After Rotationplasty Surgery, Jani Learns to Accept and Embrace Her Body

This osteosarcoma survivor uses her cancer experience to help others love and accept their bodies as they are.

Share Your Story

Fill out the form below to tell us about yourself. Sharing stories of osteosarcoma families helps us raise awareness and funds for much-needed research.

Gavin, Osteosarcoma Patient 

Explore & Discover

Stories of research, progress and exploration

The Osteosarcoma Institute to Announce New Grant Recipients

The Osteosarcoma Institute to Announce New Grant Recipients

A record 26 submissions will result in grantees who are working to transform research and treatment for osteosarcoma, a rare form of bone cancer ...
A Brief History of Osteosarcoma Treatment

A Brief History of Osteosarcoma Treatment

By Lee Helman, MD There has been a lack of improvement in outcomes for osteosarcoma patients over the last 40 years. Osteosarcoma is a very ...

Treatment and Care

No results found.

Press Room

OSI News & updates

The Osteosarcoma Institute to Fund Clinical Trial in Recurrent Osteosarcoma

The Osteosarcoma Institute (OSI) announced today that it has awarded a grant to Dana-Farber/Boston Children’s Cancer and Blood Disorders Center for a Phase II single arm study of olaparib (an FDA-approved PARP inhibitor) and ceralacertib/AZD6738 (an investigational ATR kinase inhibitor) in ...

The Osteosarcoma Institute Launches the Osteosarcoma Information Hotline

The Osteosarcoma Institute, in collaboration with the HonorHealth Research Institute, introduces a new source of reliable information for patients and families confronting osteosarcoma, a deadly bone cancer primarily affecting adolescents and young adults.

Instagram

Before You Go

Sign-up for our newsletter and stay up-to-date about our fight against Osteosarcoma!

Translate »